{"id":"https://openalex.org/W7203623682","doi":"https://doi.org/10.1016/j.clgc.2026.102652","title":"Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study","display_name":"Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study","publication_year":2026,"publication_date":"2026-08-17","ids":{"openalex":"https://openalex.org/W7203623682","doi":"https://doi.org/10.1016/j.clgc.2026.102652","pmid":"https://pubmed.ncbi.nlm.nih.gov/42727307"},"language":"en","primary_location":{"id":"doi:10.1016/j.clgc.2026.102652","doi":"https://doi.org/10.1016/j.clgc.2026.102652","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clgc.2026.102652","pdf_url":null,"source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021334443","display_name":"Melanie Mayer","orcid":"https://orcid.org/0000-0002-0556-5313","observed_orcids":["https://orcid.org/0000-0002-0556-5313"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Melanie Mayer","raw_affiliation_strings":["Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA. Electronic address: melanie.mayer@pennmedicine.upenn.edu"],"raw_orcid":"https://orcid.org/0000-0002-0556-5313","affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA. Electronic address: melanie.mayer@pennmedicine.upenn.edu","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070227307","display_name":"Nicholas J. Seewald","orcid":"https://orcid.org/0000-0002-8367-0522","observed_orcids":["https://orcid.org/0000-0002-8367-0522"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas J. Seewald","raw_affiliation_strings":["Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022423631","display_name":"Ernesto Ulloa\u2010P\u00e9rez","orcid":"https://orcid.org/0000-0003-0568-5929","observed_orcids":["https://orcid.org/0000-0003-0568-5929"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernesto Ulloa-P\u00e9rez","raw_affiliation_strings":["Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082742595","display_name":"Blanca Homet Moreno","orcid":"https://orcid.org/0000-0001-6712-8330","observed_orcids":["https://orcid.org/0000-0001-6712-8330"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Blanca Homet Moreno","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062347312","display_name":"Chethan Ramamurthy","orcid":"https://orcid.org/0000-0003-3935-9638","observed_orcids":["https://orcid.org/0000-0003-3935-9638"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chethan Ramamurthy","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":"https://orcid.org/0000-0003-3935-9638","affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013978259","display_name":"Aram Babcock","orcid":"https://orcid.org/0000-0003-0372-834X","observed_orcids":["https://orcid.org/0000-0003-0372-834X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aram Babcock","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":"https://orcid.org/0000-0003-0372-834X","affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100616462","display_name":"Haojie Li","orcid":"https://orcid.org/0009-0001-7030-6780","observed_orcids":["https://orcid.org/0009-0001-7030-6780","https://orcid.org/0000-0001-6233-8603"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haojie Li","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055266545","display_name":"Ronac Mamtani","orcid":"https://orcid.org/0000-0002-8267-5356","observed_orcids":["https://orcid.org/0000-0002-8267-5356"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronac Mamtani","raw_affiliation_strings":["Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021334443"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":{"value":3530,"currency":"USD","value_usd":3530},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"8","first_page":"102652","last_page":"102652"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enfortumab-vedotin","display_name":"enfortumab vedotin","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/advanced-urothelial-carcinoma","display_name":"advanced urothelial carcinoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.6340000033378601},{"id":"https://openalex.org/keywords/time-on-treatment","display_name":"time on treatment","score":0.7350000143051147},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/cisplatin-ineligible-patients","display_name":"cisplatin-ineligible patients","score":0.9070000052452087},{"id":"https://openalex.org/keywords/real-world-treatment-patterns","display_name":"real-world treatment patterns","score":0.7680000066757202},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7680000066757202},{"id":"https://openalex.org/keywords/accelerated-approval","display_name":"accelerated approval","score":0.5979999899864197},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.5210000276565552},{"id":"https://openalex.org/keywords/flatiron-health","display_name":"Flatiron Health","score":0.7490000128746033},{"id":"https://openalex.org/keywords/oncology-networks","display_name":"oncology networks","score":0.4090000092983246},{"id":"https://openalex.org/keywords/metastatic-bladder-cancer","display_name":"metastatic bladder cancer","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9458000063896179},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7278000116348267},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.597100019454956},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5525000095367432},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5232999920845032},{"id":"https://openalex.org/C3020144179","wikidata":"https://www.wikidata.org/wiki/Q10871684","display_name":"Electronic health record","level":3,"score":0.46230000257492065},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4553999900817871},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.44359999895095825},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4244000017642975},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.42309999465942383},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.3889000117778778},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3750999867916107},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33629998564720154},{"id":"https://openalex.org/C3019952477","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Health records","level":3,"score":0.3264999985694885},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3248000144958496},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.3190000057220459},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3172000050544739},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.29249998927116394},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.28760001063346863},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2870999872684479},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.271699994802475},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.2712000012397766},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.2676999866962433},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.2632000148296356},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.2551000118255615}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clgc.2026.102652","doi":"https://doi.org/10.1016/j.clgc.2026.102652","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clgc.2026.102652","pdf_url":null,"source":{"id":"https://openalex.org/S71328803","display_name":"Clinical Genitourinary Cancer","issn_l":"1558-7673","issn":["1558-7673","1938-0682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Genitourinary Cancer","raw_type":"journal-article"},{"id":"pmid:42727307","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42727307","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical genitourinary cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2055557358","https://openalex.org/W2738833037","https://openalex.org/W2915663023","https://openalex.org/W4392498919","https://openalex.org/W4401743023","https://openalex.org/W4404374500"],"related_works":["https://openalex.org/W4407700097","https://openalex.org/W7133196324","https://openalex.org/W7134186756","https://openalex.org/W7143323852","https://openalex.org/W7133202611","https://openalex.org/W7169764922","https://openalex.org/W7162632674","https://openalex.org/W7162699335","https://openalex.org/W4376881462","https://openalex.org/W7203906304"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-08-18T00:00:00"}